Clover Health Investments Corp (NAS:CLOV)
$ 3.17 -0.13 (-3.94%) Market Cap: 1.59 Bil Enterprise Value: 1.32 Bil PE Ratio: 0 PB Ratio: 4.85 GF Score: 34/100

Clover Health Investments Corp at Canaccord Genuity Growth Conference Transcript

Aug 09, 2023 / 12:00PM GMT
Release Date Price: $1.39 (+4.51%)
Richard Close;Andrew Toy
Canaccord Genuity Group Inc. - Analyst;Clover Health Investments,

All right. We're going to go ahead and kick off the conference this morning. Thank you for attending the Canaccord Genuity Growth Conference. I'm Richard Close. I head up the digital and tech-enabled health research here at Canaccord.

So we're kicking off this morning, I think the third year that Clover has been at our conference. And Clover competes in the Medicare Advantage area, also through the CMS ACO REACH program, really highlighted by bringing an innovative technology platform to lower costs and, more importantly, improve health outcomes. So from management, we have CEO, Andrew Toy, who took over last year; and then in the audience, CFO, Scott Leffler, too.

So Andrew, maybe just kicking off, you reported last night -- made me have a late night. So maybe we can just jump into that for a minute and set the table. Why don't you just give us a two-minute introduction to Clover: what the company does, why you do it. Then we'll get into the second-quarter report.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot